Revenue Breakdown
Composition ()
No data
Revenue Streams
Paranovus Entertainment Technology Ltd (PAVS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Lucidum spore powder products, accounting for 51.3% of total sales, equivalent to $17.28M. Other significant revenue streams include Others and Cordyceps mycelia products. Understanding this composition is critical for investors evaluating how PAVS navigates market cycles within the Software industry.
Profitability & Margins
Evaluating the bottom line, Paranovus Entertainment Technology Ltd maintains a gross margin of 19.98%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -5.06%, while the net margin is -4.70%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively PAVS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, PAVS competes directly with industry leaders such as MEHA and SCNI. With a market capitalization of $4.93M, it holds a leading position in the sector. When comparing efficiency, PAVS's gross margin of 19.98% stands against MEHA's 57.75% and SCNI's -164.29%. Such benchmarking helps identify whether Paranovus Entertainment Technology Ltd is trading at a premium or discount relative to its financial performance.
